Search Results - "Meyer, Wally G."

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 by JONES, Stephen, HOLMES, Frankie Ann, HYMAN, William J, RICHARDS, Donald A, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Wally G, ASMAR, Lina, MACKEY, Daniel, RIEDEL, Stefan, MUSS, Hyman, SAVIN, Michael A, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, VUKELJA, Svetislava J, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert L, SANDBACH, John

“…We previously reported that four cycles of docetaxel/cyclophosphamide (TC) produced superior disease-free survival (DFS) compared with four cycles of…”
Get full text

The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer by Osborne, Cynthia R., Duncan, Anita, Sedlacek, Scot, Paul, Devchand, Holmes, Frankie, Vukelja, Svetislava, Kasper, Michael, Wilks, Sharon, Schneider, Andrew, McGee, Richard, Meyer, Wally G., O’Shaughnessy, Joyce A.

“…Tamoxifen significantly reduces the risk of developing breast cancer in women at increased-risk. The usefulness of tamoxifen has been limited by its side…”
Get full text